Completed
Topics
This 4-part virtual public workshop provided a venue for stakeholders to consider a transformed clinical trials enterprise for 2030. Workshop participants considered lessons learned from progress and setbacks over the past 10 years, since the previous workshop, Envisioning a Transformed Clinical Trials Enterprise in the United States, and, looking forward, discussed goals and key priorities for advancing a clinical trials enterprise that is more efficient, effective, patient-centered, and integrated into the health delivery system of 2030. The workshop was hosted by the National Academies Forum on Drug Discovery, Development, and Translation.
Events